Why Don't Billionaires Invest In Longevity?

Longevity tech tree is unlocked now — mirrors AI circa 2012.
- Breakthroughs compound: one unlock enables the next.
- Optimal entry is when most still call it impossible.
Enabling stack: CRISPR, cellular reprogramming, gen-AI protein design, multi-omics.
- Generative AI now synthesizes bespoke proteins on demand.
- Multi-omics platforms reveal aging’s molecular signatures at scale.
Three investable categories: replacement biology, cell reprogramming, novel delivery.
- Renewal Bio, eGenesis: synthetic organs and stembroids.
- Altos Labs, Retro Biosciences: reverting cells to younger state.
- Dyno Therapeutics, Mana Bio: tissue-targeted vectors and next-gen LNPs.
Billionaires’ 1% of collective wealth → 10+ healthy years gained globally.
- Smallpox eradication cost ~0.05% of current billionaire wealth; saved millions.
Five blockers: snake oil history, feasibility doubt, powerlessness, status gaming, reputational risk.
- Forbes rank culture gamified wealth accumulation over impact.
- “Tech bro side-quest” stigma deters institutional capital.
Trillion-dollar market dwarfs current longevity market cap combined.
NFX call: “The race to 160 has begun.”

r/collapse: “The billionaires funding longevity research have also built blast-resistant bunkers, acquired offshore citizenship…” (750 pts, 100 comments)

Omri Drory, Ph.D. — General Partner, NFX · 2025-05-15 · Read on nfx.com

Reddit